NCT02212678View on ClinicalTrials.gov

Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Parkinson Disease
Interventions
DRUG

N-acetylcysteine capsule

N-acetylcysteine capsule

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Parkinson's Disease Society of the United Kingdom

UNKNOWN

lead

University of Minnesota

OTHER

NCT02212678 - Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter